Rhumbline Advisers Bioventus Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Bioventus Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 65,093 shares of BVS stock, worth $440,028. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,093
Previous 53,960
20.63%
Holding current value
$440,028
Previous $493,000
12.78%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BVS
# of Institutions
144Shares Held
49.5MCall Options Held
85.1KPut Options Held
13K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$88 Million30.91% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$46.9 Million19.48% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.28MShares$35.7 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$18.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$16 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $417M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...